PRESS RELEASE published on 09/08/2026 at 07:30, 1 month 20 days ago Informations privilégiées / Autres communiqués GenSight Biologics fait un point sur ses activités de fabrication, cliniques et financières, confirmant la date de publication des comptes semestriels 2026 Fabrication GenSight Biologics Thérapies Géniques Comptes Semestriels Actifs Cliniques
BRIEF published on 07/08/2026 at 19:16, 3 months 20 days ago GenSight Biologics presents its financial situation and therapeutic advances Treasury GenSight Biologics Phase III RECOVER Early Access GS010/LUMEVOQ®
BRIEF published on 07/08/2026 at 19:16, 3 months 20 days ago GenSight Biologics présente sa situation financière et ses avancées thérapeutiques Trésorerie GenSight Biologics Phase III RECOVER GS010/LUMEVOQ® Accès Précoce
BRIEF published on 07/08/2026 at 19:16, 3 months 20 days ago GenSight Biologics annonce sa situation de trésorerie et des mises à jour sur ses activités Essais Cliniques Actualités Commerciales Position De Trésorerie Programmes D'accès Anticipé Processus De Fabrication
BRIEF published on 07/08/2026 at 19:16, 3 months 20 days ago GenSight Biologics Announces Cash Position and Business Updates Cash Position Clinical Trials Business Updates Early Access Programs Manufacturing Process
PRESS RELEASE published on 07/08/2026 at 19:11, 3 months 20 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation de trésorerie au 30 juin 2026 et fait un point sur son activité. La trésorerie est de 1,7 million d'euros, encaissant 6,8 millions d'euros au titre de ses programmes d'accès précoce Trésorerie GenSight Biologics Thérapies Géniques Neuropathie Optique Programmes D'accès Précoce
PRESS RELEASE published on 07/08/2026 at 19:11, 3 months 20 days ago Inside Information / News release on accounts, results GenSight Biologics reports cash position updates as of June 30, 2026, along with business developments, including proceeds from early access programs and manufacturing process improvements Cash Position Business Updates GenSight Biologics Early Access Programs Manufacturing Process
BRIEF published on 04/28/2026 at 20:40, 6 months ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 6 months ago GenSight Biologics programme son assemblée générale annuelle pour mai 2026 Conformité Réglementaire Assemblée Générale Annuelle Thérapie Génique Relations Avec Les Investisseurs Informations Destinées Aux Actionnaires
BRIEF published on 04/28/2026 at 20:40, 6 months ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
Published on 10/28/2026 at 22:35, 2 hours 40 minutes ago Route1 Announces Third Quarter and Year to Date 2026 Financial Results Notification
Published on 10/28/2026 at 12:30, 12 hours 45 minutes ago Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 12 hours 45 minutes ago AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 12 hours 45 minutes ago Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 12 hours 45 minutes ago Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/29/2026 at 00:15, 1 hour ago Infinite Electronics Showcases Engineered Connectivity Solutions at electronica 2026
Published on 10/28/2026 at 21:35, 3 hours 40 minutes ago Food & Beverage Manufacturers Race to Scale AI Beyond the Pilot Stage
Published on 10/28/2026 at 20:36, 4 hours 38 minutes ago Vonovia’s Core Business Remains Resilient as Higher Financing Costs and Weaker Transaction Business Shape 2027 Guidance and 2028 Objectives
Published on 10/28/2026 at 17:56, 7 hours 19 minutes ago OPR - Mise à disposition de l'addendum au rapport d'expertise indépendante
Published on 10/28/2026 at 17:45, 7 hours 30 minutes ago VOGO obtains FIBA (International Basketball Federation) Approval for its Instant Replay System.
Published on 10/28/2026 at 17:45, 7 hours 30 minutes ago Successful issue of a € 6.0 billion bond as part of the financing of the PTC acquisition
